Introduction
As both lack and excess of iron are pathological, vertebrates control iron balance at the cellular and the systemic level by coordinating iron uptake, storage, export, and distribution (for a recent review, see Hentze et al. 1 ). For systemic iron uptake, dietary iron is transported from the intestinal lumen into the cytoplasm of duodenal enterocytes via DMT1/Slc11A2 2 . The ubiquitously expressed transferrin (Tf) receptor 1 (TfR1) is thought to supply body cells with iron by internalisation of serum Tf. Some specialized macrophages acquire iron indirectly by breaking down heme following phagocytosis of senescent erythrocytes. Iron that enters cells and is not used can be sequestered within heteropolymers of ferritin H-and L-chain. The mechanisms by which cells export iron are less well understood. Ferroportin/Slc40A1, located at the basolateral membrane of duodenal enterocytes, exports iron into the bloodstream and loads it onto plasma apo-Tf 3 , probably in conjunction with the feroxidase hephaestin. Ferroportin is also expressed by e.g. macrophages and hepatocytes [3] [4] [5] where it acts in concert with ceruloplasmin 3, 6 .
Systemic iron homeostasis requires communication between cells that need iron (mainly erythroid precursors) and cells that acquire (duodenal enterocytes), store (hepatocytes and tissue macrophages) or recycle (tissue macrophages) iron. As no pathway for regulated iron excretion is known, control of intestinal iron absorption is critical for maintenance of adequate body iron levels. Duodenal iron absorption responds to changes in dietary iron intake, the status of the iron stores, and erythropoietic activity 7 . Hepcidin (Hamp), a soluble -defensin-like polypeptide excreted mostly by the liver decreases duodenal iron absorption and iron release from macrophages by inhibition of ferroportin 8 . Hamp mRNA levels decrease in response to iron deficiency and anemia, while dietary iron overload stimulates Hamp expression 9 .
For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From 4 Cellular iron metabolism is coordinately controlled by Iron Regulatory Proteins (IRPs) 1 and 2 that bind to Iron-Responsive Elements (IRE), cis-regulatory RNA motifs present in untranslated regions (UTR) of mRNAs encoding proteins of iron uptake (TfR1, DMT1), storage (ferritin Hand L-chain), export (ferroportin), or utilization (mitochondrial aconitase, 5-aminolevulinate synthase). Independently, both IRPs inhibit translation when bound to IREs present in the 5'UTR (e.g. ferritin, 5-aminolevulinate synthase, mitochondrial aconitase, ferroportin mRNAs), whereas their association with the IREs present in the 3'UTR of the TfR1 mRNA prevents its degradation 1 . The IRE-binding activity from both IRPs is high in iron-deficient cells and low under conditions of iron load. Failure to coordinate the expression of IRE-containing genes is associated with pathological conditions as illustrated by the autosomal dominant hyperferritinemia-cataract syndrome observed in patients carrying mutations in the ferritin L IRE 10, 11 , by the autosomal dominant iron overload in patients with a mutation in the ferritin H IRE 12 , or by a progressive neurodegenerative disorder observed in aged mice lacking IRP2 13 .
The role of the IRP/IRE regulatory network in cellular homeostasis has been extensively investigated in cell culture 1, [14] [15] [16] . The respective roles of IRP1 and IRP2 in mammalian physiology are only beginning to be investigated 13, [17] [18] [19] . To address the role of the IRP/IRE regulatory network in systemic iron metabolism, we developed mouse lines with targeted disruptions of the irp1 or irp2 loci 18 . A detailed analysis of the phenotype of mice lacking IRP2 uncovers a novel role of IRP2 in systemic iron metabolism. We address the mechanisms underlying the misregulation of systemic iron homeostasis in IRP2-/-mice.
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Mice.
The generation of the IRP2-deficient mice has been described 18 . A Geo gene-trap construct was inserted into the second intron of the irp2 locus to interrupt the open reading frame near the amino-terminus, thereby creating a functional null allele. The selection cassette was co-inserted with LoxP sites flanking exon 3 for excision by the Cre recombinase. Heterozygotes on a mixed Sv129/Ola / C57BL6/J genetic background were intercrossed to obtain +/+, +/-and -/-littermates. Animals were kept under a constant light/dark cycle. The iron content of the standard diet was 200 mg/kg. Mice were made iron-deficient by feeding a low iron diet (< 10 mg/kg) vs. a control diet (C1038 and C1000, respectively, Altromin, Lage, Germany) for 25 days starting from weaning age. 10-week old females were injected intraperitoneally with phenylhydrazine (60 mg/kg of body weight) or NaCl 0.9% on two consecutive days and sacrificed 3 days after the last injection. Heparinized blood was collected by cardiac puncture. Longitudinal sections of the proximal duodenum were collected first. Bone marrow cells were flushed out of the femur with ice-cold PBS and pelleted by centrifugation for RNA and protein extraction. Animal handling was in accordance with institutional guidelines.
Hematology and iron determination.
Serum iron and unsaturated iron binding capacity (UIBC), respectively, were determined using the Total iron assay and UIBC assay reagents (Diagnostic Chemicals Limited, Charlottetown, Canada) together with the calibrators and standards recommended by the manufacturer. Blood
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Total non-heme iron was measured using the bathophenantroline chromogen (Sigma, Taufkirchen, Germany) as described by Torrance and Bothwell 20 with the modifications described by Patel et al. 21 .
Determination of duodenal iron transport.
Duodenal iron transfer was determined as described previously 22 . 12-week old mice were fasted overnight. A tied-off duodenal segment (2-3 cm) was flushed with saline (37°C), filled in situ with 50-100 µl of physiological medium (125 mM NaCl, 3.5 mM KCl, 10 mM D-glucose, 16
mM Na-HEPES, pH 7.4), containing 100 µM 59 Fe 3+ :nitrilotriacetate 1:2 (NEN, NEZ37, Dreieich, Germany). The ligated duodenal segment was removed after 15 min, ligating the mesenteric blood supply to avoid blood losses. The radioactivity associated with the carcass was measured in a whole body counter (ARMAC 446, Packard, Palo Alto, CA, USA) 22 .
RNA analyses.
Total RNA was extracted using the Trizol reagent (Invitrogen, Karlsruhe, Germany) and a polytron homogeniser (Kinematika, Lucerne, Switzerland). Northern-blotting was done following standard procedures, using a -actin probe to assess equal loading. Signals were quantified using a fluorimager (Fujifilm FLA-2000, Amersham Biosciences, Freiburg, Germany). Microarray experiments were carried out as described previously 23, 24 using the Mouse Version 3.0 of the "IronChip".
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Templates for RNase protection assays were generated by PCR from murine cDNAs using the primers 5'-GATGAATGACTTCCTGAATGTC-3'  (sense)  and  5'-TAGTCATCTGGACACCACTG-3'  (reverse)  (DMT1  3' variants), 5'-AACACTGTTGTCAGAGAAGTTG-3' (sense) and 5'-ATTCACAGAATAACTTAGTTCTTC-3' (reverse) (Tfr1), 5'-AGATCTGTGAAGAATAGAGAGCCTAG-3' (sense) and 5'-GCTGCAGGGGTGTAGAGAGGTC-3' (reverse) (Hepcidin 1 and 2). The PCR products were cloned into the pCRII Topo vector (Invitrogen). The templates were linearized with BamHI (DMT1), XhoI (TfRI), or BglII (hepcidin) and antisense probes were generated by in vitro transcription using the T7 (DMT1, hepcidin) or the SP6 (TfRI) RNA polymerases (Stratagene, Amsterdam, The Netherlands). 5 µg of total RNA were used for RNase protection assay using the RPA-III kit (Ambion, Huntingdon, Cambridgeshire, United Kingdom). RNA samples were co-hybridised with a -actin probe from the kit. Protected products were resolved on denaturing acrylamide gels and subjected to autoradiography using a fluorimager (Fujifilm FLA-2000, Amersham Biosciences).
Protein analyses.
Protein extracts were prepared and subjected to western-blot analysis as described previously 18 except that for the detection of ferroportin the samples were not heated prior to loading. Ferritin H and L subunits were detected using the goat polyclonal antibodies sc-14416 and sc-14420, respectively (Santa Cruz Biotechnology, Heidelberg, Germany). -actin (clone AC-15) and TfR1
were detected using mouse monoclonal antibodies, respectively, from Sigma and Zymed (Berlin, Germany). Ferroportin and IRP2 were detected using immuno-purified rabbit polyclonal antibodies raised, respectively, against a peptide corresponding to the C-terminus of ferroportin To evaluate the consequences of IRP2 deficiency on systemic iron metabolism, tissue iron was measured in the liver, a site of iron storage, in the duodenum, the site of iron absorption, and in the spleen, a major site of iron recycling, as well as in the brain (table 1) . Non-heme iron content is increased in the liver (by ~ 50%) and duodenum (by ~ 80%), in agreement with earlier observations on older animals of a distinct IRP2 KO mouse line 13 . By contrast, the spleen of IRP2-/-mice displays a relative iron deficiency (by ~ 40%) that was not reported before. Nonheme iron levels in the brain are unchanged.
To assess the impact of the abnormal iron distribution on the major systemic iron utilization pathway, we determined the hematolgical parameters (table 2) . While leucocyte counts are normal, the hematocrit and serum hemoglobin values are significantly reduced in spite of normal erythrocyte counts, with lower MCV values (microcytosis) in both male and female IRP2-/-mice.
Considering the accumulation of iron in the duodenum and the liver, IRP2-/-mice could be microcytic because of decreased systemic iron availability. However, serum iron levels, the total iron binding capacity, and the serum transferrin saturation do not significantly differ between IRP2-/-mice and their wild-type littermates (table 3) . Thus, IRP2-deficient mice are mildly
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Duodenal iron metabolism in IRP2-/-mice.
To better understand the iron accumulation in the duodenum of IRP2-deficient mice, we performed Prussian Blue staining (Fig. 1A , upper panels). Confirming the increase in non-heme iron content detected with the bathophenantroline method (table 1), iron deposits are evident in the duodenal villi but not crypts of IRP2-/-mice, suggesting that iron deposits do not result from increased uptake of plasma iron via TfR1 which is preferentially expressed in crypt cells 26 .
Immunostaining reveals ferritin H-and L-chain expression that mirrors the increase in iron A rise in iron and ferritin levels in IRP2-/-enterocytes could be explained by increased iron influx, decreased efflux, or retention of iron within ferritin that is translationally de-repressed.
Next, we examined the expression of DMT1 and ferroportin, the apical and the basolateral iron transporters, respectively. Four isoforms of DMT1 that differ in their N-and C-termini are generated by a combination of alternative splicing and the use of alternative promoters and polyadenylation sites 27 . We analysed DMT1 mRNA expression by RNase protection assay, focusing on the variants that differ by the absence (noIRE form) or the presence (IRE form) of an IRE motif in the 3' UTR 28 ( Fig. 2A) . The increased DMT1 mRNA expression, especially of the IRE form, was ascertained in duodenal samples of iron-deficient mice ( Fig. 2A) as a positive control for regulation 29 . Analysis of groups of four IRP2+/+, +/-and -/-mice reveals no significant variation in the expression of the DMT-1 mRNA isoforms. Confirming mRNA data, DMT1 protein expression was readily detected by western blotting in iron-deficient mice, whereas basal DMT1 levels remained below the detection limit in both wild-type and IRP2-/-mice (data not shown).
In the same mice, ferroportin levels are subject to significant interindividual variability ( Fig. 3B ), but combining the results obtained from three independent lots of mice shows that ferroportin expression is not significantly altered in IRP2-/-mice, either at the mRNA or the protein level.
We analysed ferroportin protein expression in total protein extracts, which does not discriminate cell surface-exposed from intracellular protein. However, internalised ferroportin is targeted for degradation 8 and should therefore contribute little to the total ferroportin signal.
Dcytb, an iron reductase thought to act in conjunction with DMT1, may act as a facilitator of iron overload in HFE KO mice 30 . A comparison of duodenal mRNA expression patterns between IRP2-/-and +/+ mice using the "IronChip" 24 2D ) and DMT1 mRNA, especially the IREcontaining variant (Fig. 2C ) mirrored by the level of the corresponding DMT1 protein (data not shown). In addition, an IronChip analysis revealed the appropriate upregulation of the Dcytb mRNA (data not shown). Importantly, the response of IRP2-/-mice to PHZ is identical to that of wild-type mice ( Fig. 2C and 2D ). These data show that a mild reduction of the hematocrit and serum hemoglobin values in IRP2-deficient mice fails to elicit alterations in duodenal expression of DMT1 and ferroportin, although the regulatory network in IRP2-/-mice is able to respond to PHZ-induced anemia.
To investigate the functional consequences of increased ferritin levels in the duodenum, we studied duodenal iron transfer in situ by injecting 59 Fe into the lumen of the gut and measuring the radioactivity recovered in the body after 15 minutes. The rate of iron transport across the duodenal mucosa is similar in IRP2-/-mice and wild-type littermate controls (Fig. 2E) . Thus, the increase in the ferritin content of enterocytes of IRP2-/-mice does not detectably affect the Hepatic iron metabolism in IRP2 deficiency.
As the livers of IRP2-/-mice also display iron loading, ferritin H-and L-chain expression was analysed by western blotting (Fig. 3 , upper panels). L-chain expression is increased 6-fold in IRP2-/-mice. Ferritin H-chain expression is below the detection limit in the liver of wild-type mice, but is detectably increased in IRP2-/-animals. Ferritin H-and L-chain mRNA levels are unchanged (Fig. 3 , lower panels), showing that ferritin expression is increased posttranscriptionally. By contrast, IRP2-/-mice display a faint reduction of TfR1 levels (data not shown), suggesting that the accumulation of iron and ferritin in the liver of IRP2-deficient mice occurs without constitutive increase in TfR1-dependent iron acquisition.
Considering both the liver iron accumulation (table 1) and the reduced hematocrit (table 2) , we determined hepcidin expression. Hepcidin mRNA levels show interindividual variability in mutant mice as well as in wild-type littermates. Combining the results from three independent lots of mice, we observe a slight increase, although not statistically significant, in hepcidin mRNA expression in IRP2-/-vs. +/+ mice (Fig. 4A) . Unlike humans, mice express two hepcidin genes. The two hepcidin proteins may play distinct roles in iron homeostasis 33 . Given their 92% sequence identity 34 , the hepcidin 1 and 2 mRNAs cannot be discriminated by Northern blotting.
To check whether IRP2-mutant mice regulate hepcidin 1 and 2 mRNAs selectively, RNase protection experiments were performed with brain mRNA as a negative control (Fig. 4B) . As a
control for regulation, we analysed hepcidin mRNA expression in females that received an ironpoor vs. a control diet. In control mice, both hepcidin mRNAs are detected (Fig. 4B) . Irondeficient female mice display the expected decrease in both hepcidin 1 and hepcidin 2 mRNA levels, while hepcidin 2 mRNA is barely detectable in IRP2+/+ and -/-males, which express predominantly hepcidin 1. This difference is likely explained by the sex difference since gender has been shown to affect the hepcidin1/hepcidin2 ratio 35 . In agreement with the northern-blot data, we do not observe significant changes in hepcidin 1 mRNA levels in IRP2-deficient compared to wild-type mice. This observation is surprising since a reduction in hematocrit and serum hemoglobin values is expected to elicit hepcidin downregulation. To test whether or not IRP2-deficient mice can adequately adjust hepcidin expression in response to decreased hematocrit and serum hemoglobin values, mice were injected with PHZ as described above.
Wild-type mice respond with the expected dramatic reduction in hepcidin mRNA expression (Fig. 4C) . Importantly, the response of IRP2-/-mice to PHZ is identical, showing that IRP2 deficiency does affect the control of hepcidin expression in response to hemolytic anemia.
Altered iron metabolism in the spleen of IRP2-deficient mice.
In agreement with a decrease in non-heme iron content (table 1) , sections from the spleens of IRP2-/-mice show weaker Prussian Blue staining in the red pulp (Fig. 5A, upper panels) . This staining essentially reveals macrophages and is associated with weaker immunostaining for the ferritin L-chain (Fig. 5A, lower panels) , and a reduction in ferritin H (~1.5 fold) and L (~2 fold) expression in western blots of splenic extracts from IRP2-/-mice (Fig. 5B, upper panels) . The levels of the corresponding mRNAs are unchanged (Fig. 5B , lower panels), suggesting posttranscriptional downregulation. We detected no signs of erythroid hyperplasia that could
explain the iron deficiency of splenic macrophages. Indeed, IRP2-/-mice display no splenomegaly, and the mRNA levels encoding the heme biosynthetic pathway enzymes ferrochelatase or eALAS are normal as assessed with the IronChip (supplementary informations). By contrast, the levels of these mRNAs increase when the mice are made strongly anemic by PHZ injection (data not shown).
The iron deficiency of splenic macrophages could be due to increased iron export and/or decreased iron acquisition. Several observations indicate that ferroportin is a major mediator of iron efflux from macrophages 36, 37 . Overexpression (or activity) of ferroportin could hence explain an iron deficiency of splenic macrophages. Alternatively, if the splenic iron deficiency was caused by reduced iron acquisition, ferroportin mRNA translation might be repressed via IRP1. Thus, determination of ferroportin expression could help distinguish between these scenarios. In the spleen, ferroportin is detected mostly in macrophages expressing the F4/80 antigen 4 . In F4/80 positive cells of IRP2-/-spleens, total ferroportin protein expression is reduced, without a concomitant change in ferroportin mRNA levels (Fig. 6 ). This result directly supports the second hypothesis according to which the iron deficiency is more readily explained by reduced iron acquisition than by increased export. A similar decrease in total ferroportin expression at the posttranscriptional level was observed in the bone marrow of IRP2-/-mice, another major site of iron recycling (data not shown).
Decreased erythroid TfR1 expression can account for the microcytosis.
Microcytosis in IRP2-/-mice is associated with iron redistribution within the liver-bone marrowspleen axis. Nonetheless, serum iron levels and transferrin saturation are not detectably altered,
suggesting that the microcytosis could result from an intrinsic defect in hematopoiesis. To test 18 , to extend and complement phenotypic studies on mice with constitutive deletions of IRP1 and/or IRP2 13, 17 . The detailed analyses of mice lacking IRP2 expression reported here have uncovered a previously unrecognised function of IRP2 in securing physiological iron distribution between the duodenum, the liver and the spleen, and the need for IRP2 expression for normal erythropoiesis.
Altered iron metabolism in IRP2-deficient mice.
IRP2-deficient mice display mild microcytosis with reduced hematocrit and serum hemoglobin values, associated with altered iron distribution in the central iron recycling system, the liverbone marrow-spleen axis, and iron deposits in the duodenal mucosa. Notably these alterations occur without detectable change in hepcidin mRNA levels. However, the lack of IRP2 does not disrupt the physiological regulation of hepcidin in severely anemic mice following PHZ injection. This result indicates that the reduced hematocrit of IRP2-/-animals may not have reached the threshold required for hepcidin to respond. Similarly, the iron accumulation in the liver of IRP2-/-mice may not be sufficient to trigger hepcidin expression, or it may fail to be sensed as iron overload as a result of its cellular or subcellular distribution. Conceivably, the antagonistic effects of microcytosis and liver iron loading on hepcidin expression could neutralize each other.
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The reasons for the altered iron distribution in IRP2-/-mice are not fully resolved. While liver iron loading and macrophage iron deficiency are reminiscent of type 1 hemochromatosis, the normal serum Tf saturation and the enterocyte iron loading are not 40 . Furthermore, the IronChip analysis revealed unchanged HFE mRNA expression in various organs (supplementary material).
The phenotypic manifestations of IRP2 deficiency have several other interesting implications.
The increased expression of ferritin in enterocytes on the one hand and the unaffected expression of duodenal iron transport molecules, the normal duodenal transfer of 59 Fe and the normal serum transferrin saturation on the other are striking in terms of the mucosal block hypothesis proposed by Crosby 41 . This hypothesis states that duodenal ferritin serves to withhold iron from entering into circulation and thus as a means to negatively regulate iron transfer. IRP2-/-mice with an 8-to 9-fold increase in ferritin and seemingly normal iron transfer appear to uncouple the two events in a way that is not predicted by the mucosal block scenario. One critical issue is whether IRP2-deficient mice are microcytic because of iron mismanagement within the iron-recycling pathway. Normal serum iron levels and transferrin saturation values suggest that this is not the case. As mice with haploinsuficiency for TfR1 suffer from microcytosis 38 , the ~1.6-fold reduction of TfR1 mRNA expression accompanied by diminished TfR1 protein expression in erythroid cells of IRP2-/-mice can plausibly explain the microcytosis. We did not find increased ferritin expression in total bone marrow samples that could withhold a fraction of the iron needed for erythropoiesis. However, changes in ferritin levels in erythroid precursors might be masked by the contribution of ferritin from the other cells of the bone marrow. Indeed, Cooperman et al.
recently reported a small increase in ferritin expression in eryhtroid precursors sorted from the bone marrow of a distinct IRP2-deficient line 42 . Although Western blotting detected no changes in eALAS accumulation in total bone marrow extracts from our IRP2-/-mice (data not shown), 42 , associated with accumulation of free protoporphyrin IX. Altogether these data suggest that microcytosis in IRP2-/-mice is likely caused by an intrinsic defect of intracellular iron availability in erythroid cells.
Using a gene replacement vector to target the irp2 locus non-conditionally, LaVaute et al. 13 described the development of a progressive neurodegenerative disease with locomotor impairment in IRP2-/-mice older than 6 months. We have not observed any overt signs of neuropathology such as tremor or any obvious postural abnormality in young adults as well as in 8-month old IRP2-/-mice (data not shown). While both IRP2-deficient mouse lines display duodenal and hepatic accumulation of iron and ferritin, we did not observe increased ferroportin and DMT1 expression in the duodenum as reported by LaVaute et al. 13 . Several factors could explain such discrepancies. While both mouse lines are on similar mixed C57BL6/Sv129 genetic backgrounds, they were analysed at a different age (8) (9) (10) weeks in the present study versus 4 months and older in LaVaute et al. 13 ). However, we tested but did not detect significantly increased duodenal ferroportin expression in 4 and 8 month-old IRP2-/-mice either (data not shown). Perhaps more importantly, the targeting strategies are distinct. While LaVaute et al. 13 used a gene replacement vector bearing a PGK-Neo cassette, we inserted a promoter-less Geo gene-trap construct into an early intron of the irp2 gene 18 . Artefacts arising from selection markers are well documented 43 . Therefore we crossed our IRP2-/-line bearing the Geo cassette with a Cre deletor strain to derive an IRP2 null line that lacks any selection marker inserts and that differs from the wild type only by the absence of exon 3. A preliminary analysis of this IRP2
/ line also displays a complete loss of IRP2 expression and shows the same phenotype as the one reported here, including the misdistribution of iron and microcytosis, and excluding 
Molecular basis of altered iron metabolism in IRP2-deficient mice.
IRP2 deficiency leads to iron accumulation in the liver and in the duodenum with a concomitant posttranscriptional increase in ferritin protein expression. The mechanisms underlying iron deposition in those tissues remain to be elucidated. We did not observe any increase in hepatic TfR1 expression in mutant animals. A second Tf receptor with about 25-fold lower affinity than TfR1, TfR2, is expressed on hepatocytes 44 . However, the IronChip analysis did not reveal any change in TfR2 mRNA expression either. Hence, a potential increase in liver iron uptake could potentially involve Tf-independent pathways. A reduction in iron efflux may also account for iron accumulation, although there is no detectable change in hepatic ferroportin expression (data not shown). Still unknown ferroportin-independent iron export pathways might be affected, or ferroportin function could be decreased posttranslationally.
Contrary to what was observed in the liver and in the duodenum, the iron and ferritin content of splenic macrophages is lower in IRP2-/-animals. Curiously, IRP2-/-macrophages from the spleen and bone marrow display reduced ferroportin expression, a finding that was not reported before 13, 42 . This is unexpected, since ferroportin downregulation should result in iron retention.
Hypothetically, an increase in the iron transport activity of ferroportin may overcome the reduction of its expression, or an as yet unknown iron export pathway may be activated. In that case, ferroportin downregulation might be secondary to iron deficiency and may result from 
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in a time-and tissue-specific manner using conditional alleles 18 provides an experimental system to further uncover the role of the IRP/IRE regulatory system in mammalian physiology. by SDS-PAGE and subjected to western-blot analysis (upper panels). Ferritin H-and L-chain mRNA levels were analysed by northern-blotting using 10 µg of total RNA from the same mice (lower panels) and -actin mRNA as a standard. Western-blot and northern-blot signals were quantified and are presented as a histogram (bottom) after normalization for -actin expression.
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In western blots, the ferritin L-subunit resolves into two bands, the lower one corresponding to a cleavage product. Both bands were taken into account for quantification. IRP2 expression was below the detection limit. Expression of ferritin H-and L-subunits was analysed in groups of four +/+, +/-and -/-mice by western-(upper panels) and northern-blotting (lower panels) using -actin as a standard. IRP2 expression is also shown; a non-specific band is indicated with an asterisk. The western-blot and northern-blot signals were quantified and results are presented in a histogram (bottom) after normalization for -actin. Ferritin H-chain was below the detection limit in wild-type mice (n.d.)
and was not quantified in IRP2-/-mice (n.q.) because of background interference. These figures A) The spleen from 10 week +/+ and -/-males was analysed by Prussian Blue staining (upper panels) or staining with an anti ferritin L-chain antibody (lower panels). Prussian blue coloration was counterstained with Nuclear Fast Red and ferritin immunostaining with Hematoxylin.
Pictures were acquired on a Axiophot microscope (Zeiss) with a 20X objective. Ferritin H-chain expression was below the detection limit and is not shown. B) IRP2 and ferritin H-and L-chain expression was analysed in groups of four +/+, +/-and -/-mice by western-(upper panels) and northern-blotting (lower panels) from 40 µg of total protein or 10 µg of total RNA, respectively, using -actin as a standard. The histogram represents the level of ferritin expression after normalization for -actin. For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
